The role of cytokines which signal through the common γ chain cytokine receptor in the reversal of HIV specific CD4+ and CD8+ T cell anergy

PLoS ONE

Volumn 2, Issue 3, 2007, Pages

  Gu, Xiao Xiao Jenny ^a   Yue, Feng Yun ^a   Kovacs, Colin M ^a,c   Ostrowski, Mario A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Canadian Immunodeficiency Research Collaborative   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA;

ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; CELL DIVISION; CHRONIC DISEASE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHRONIC DISEASE; CLONAL ANERGY; CYTOKINES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; T-LYMPHOCYTES;

EID: 34447302212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000300     Document Type: Article

References (39)

1. Reusser P, Cathomas G, Attenhofer R, Tamm M, Thiel G, et al. (1999) Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load: Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. J Infect Dis 180: 247-253.
2. Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, et al. (1997) The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A 94: 254-258.
3. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187: 1395-1402.
4. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5: 518-525.
5. Collins KL (2003) How HIV evades CTL recognition. Curr HIV Res 1: 31-40.
6. Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, et al. (2000) Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 165: 1082-1092.
7. McNeil AC, Shupert WL, Iyasere CA, Hallahan CW, Mican JA, et al. (2001) High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc Natl Acad Sci U S A 98: 13878-13883.
8. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, et al. (2002) HIV-specific CD8(+) T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 7: 7.
9. Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, et al. (2003) Diminished proliferation of human immunodeficiency virus-specific CD4+T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 77: 10900-10909.
10. Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, et al. (2002) Persistent numbers of tetramer+CD8(+) T cells, but loss of interferon-gamma+HIV-specific T cells during progression to AIDS. Blood 99: 2505-2511.
11. Vogel TU, Allen TM, Altman JD, Watkins DI (2001) Functional impairment of simian immunodeficiency virus-specific CD8+T cells during the chronic phase of infection. J Virol 75: 2458-2461.
12. Whitmire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R (1996) CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J Virol 70: 8375-8381.
13. + T cell responses associated with control of viremia. Science 278: 1447-1450.
14. Rosenberg ES, LaRosa L, Flynn T, Robbins G, Walker BD (1999) Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol Lett 66: 89-93.
15. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, et al. (2000) Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood 96: 3094-3101.
16. Goepfert PA, Bansal A, Edwards BH, Ritter GD, Jr., Tellez I, et al. (2000) A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 74: 10249-10255.
17. Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, et al. (2003) HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+T cells endowed with proliferative capacity. J Exp Med 198: 1909-1922.
18. Scriba TJ, Zhang HT, Brown HL, Oxenius A, Tamm N, et al. (2005) HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound. J Clin Invest 115: 443-450.
19. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, et al. (1998) Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 102: 1758-1765.
20. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, et al. (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176: 1099-1106.
21. Klenerman P, Meier UC, Phillips RE, McMichael AJ (1995) The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol 25: 1927-1931.
22. Geginat J, Sallusto F, Lanzavecchia A (2001) Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 194: 1711-1719.
23. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334.
24. Beverly B, Kang SM, Lenardo MJ, Schwartz RH (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4: 661-671.
25. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, et al. (2003) Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9: 540-547.
26. Lane C (1997) Limited immune recovery after treatment with antiretrovirals, IL-2; interview with Clifford Lane, M.D. Interview by John S. James. AIDS Treat News: 1-5.
27. Arno A, Ruiz L, Juan M, Jou A, Balague M, et al. (1999) Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with
28. Dybul M, Hidalgo B, Chun TW, Belson M, Migueles SA, et al. (2002) Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. J Infect Dis 185: 61-68.
29. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861.
30. Nelson BH (2004) IL-2, regulatory T cells, and tolerance. J Immunol 172: 3983-3988.
31. Biglino A, Sinicco A, Forno B, Pollono AM, Sciandra M, et al. (1996) Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 78: 61-69.
32. Clark SJ, Shaw GM (1993) The acute retroviral syndrome and the pathogenesis of HIV-1 infection. Semin Immunol 5: 149-155.
33. Niu MT, Stein DS, Schnittman SM (1993) Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 168: 1490-1501.
34. Roos MT, de Leeuw NA, Claessen FA, Huisman HG, Kootstra NA, et al. (1994) Viro-immunological studies in acute HIV-1 infection. Aids 8: 1533-1538.
35. Yue FY, Kovacs CM, Dimayuga RC, Parks P, Ostrowski MA (2004) HIV-1-specific memory CD4(+) T cells are phenotypically less mature than cytomegalovirus-specific memory CD4(+) T cells. J Immunol 172: 2476-2486.
36. Jennes W, Kestens L, Nixon DF, Shacklett BL (2002) Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15-the Amplispot assay. J Immunol Methods 270: 99-108.
37. Chitnis V, Pahwa R, Pahwa S (2003) Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15. Clin Immunol 107: 36-45.
38. Calarota SA, Otero M, Hermanstayne K, Lewis M, Rosati M, et al. (2003) Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques. J Immunol Methods 279: 55-67.
39. Liu K, Catalfamo M, Li Y, Henkart PA, Weng NP (2002) IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci U S A 99: 6192-6197.